|
Nov 8
|
With 76% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners
|
|
Nov 7
|
Zimmer Biomet (ZBH) Q3 Earnings Top Estimates, Margins Fall
|
|
Nov 6
|
Insulet (PODD) Q3 Earnings Beat, 2023 Sales Growth View Up
|
|
Nov 4
|
Calculating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
|
|
Nov 3
|
Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates
|
|
Nov 3
|
AMN Healthcare (AMN) Q3 Earnings and Revenues Beat Estimates
|
|
Nov 3
|
Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View
|
|
Nov 3
|
Stryker (SYK) Q3 Earnings Beat on Strong Segmental Result
|
|
Nov 3
|
Penumbra (PEN) Q3 Earnings Top Estimates, Margins Increase
|
|
Nov 2
|
Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
|
|
Nov 2
|
Avanos (AVNS) Q3 Earnings Top Estimates, Margins Contract
|
|
Nov 2
|
QuidelOrtho (QDEL) Q3 Earnings Top Estimates, Margins Down
|
|
Nov 2
|
Nevro (NVRO) Q3 Earnings Top Estimates, FY23 Revenue View Up
|
|
Nov 2
|
Exact Sciences (EXAS) Q3 Earnings Beat, Gross Margin Rises
|
|
Nov 2
|
Baxter (BAX) Beats on Q3 Earnings, Divests BioPharma Business
|
|
Nov 2
|
DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Lowers '23 Guidance
|
|
Nov 2
|
Glaukos (GKOS) Q3 Earnings Beat Estimates, Revenues Rise Y/Y
|
|
Nov 2
|
McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View
|
|
Nov 2
|
1 Stock Down 15% This Year to Buy and Hold Forever
|
|
Nov 2
|
Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV
|